A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.

As the rate of GLP-1 prescriptions in the U.S. has risen, the obesity rate has dropped.

Ozempic and other semaglutide medications have been working wonders in terms of shedding pounds for many people.